Davis Polk advised the representatives of the several underwriters in the offering.Akoya Biosciences, Inc. executed its $151.3 million initial public offering of 7,567,000 shares of common stock. Akoya…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
